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Following the fatal invasive meningococcal disease in a Swiss 
student who had been visiting Berlin, several public health 
institutions on local, regional and national level cooperated to 
ensure that the appropriate measures such as contact tracing and 
post exposure prophylaxis were taken to prevent further cases. The 
incidence highlighted the importance of early disease notification 
and showed that if an infectious disease requiring public health 
action occurs in an international context, it is vital that relevant 
information is communicated to all levels of the public health 
systems of the countries involved.
An 18 year-old Swiss student travelled to Berlin on a class 
trip by night train on 12/13 October 2008, where the group 
stayed at a hostel. During the night from 17 to 18 October, the 
student complained of severe headache, back pain and vomiting 
and presented at a local hospital on 18 October, where invasive 
meningococcal disease was diagnosed by culture in blood and 
cerebrospinal fluid. Despite intensive care measures, the patient 
died on 20 October. The isolate was sent to the German National 
Reference Centre for Meningococci, where the serogroup was 
determined as W135. 
Contact tracing and measures to prevent further cases 
Switzerland
The patient’s classmates returned to Basel, Switzerland by night 
train on 18 October. Before returning, the travel group informed 
the Cantonal Health Department in Basel about the situation and 
chemoprophylaxis was provided to the students immediately upon 
their arrival. The students were counselled by the child and youth 
health division of the cantonal health department and a letter 
was sent out to parents. Close household contacts of the patient, 
who had stayed in Basel received chemoprophylaxis one day later. 
In addition, a press release informing about the case and the 
chemoprophylaxis that had been carried out was issued by the 
cantonal health department in Basel on 20 October. 
Germany
The hospital in Berlin where the patient was treated notified the 
case to the local district health department by fax on Sunday, 19 
October, which in turn informed the Berlin Senate Department for 
Health, Environment and Consumer Protection (state level) and the 
Robert Koch-Institute (RKI) on 20 October 2008. Furthermore, a 
message about the incident was posted on the Early Warning and 
Response System (EWRS) on 21 October by the RKI. 
In the course of the ensuing contact tracing, information was 
repeatedly exchanged between the local health departments in 
Berlin and Basel on 20 October. The Berlin health departments 
issued a first press release on 21 October informing about the case. 
Investigations revealed that a young woman who was not part of 
the Swiss travel group had travelled to Berlin in the same train 
compartment as the patient. In addition, the patient had visited a 
local nightclub on 15 and 17 October, where classmates described 
close contact with several persons not part of the travel party. The 
local Berlin health authority therefore issued a second press release 
later on 21 October informing about symptoms and transmission 
of meningococcal disease and requesting the young woman who 
had travelled to Berlin in the same compartment, whose first name 
appeared in the press release, as well as persons who had had close 
contact with the patient in the club, to contact the local health 
department for assessment of the need for chemoprophylaxis. 
The investigations revealed that the patient had had breakfast 
in a common room at the hostel together with travel groups from 
three German federal states as well as from the Netherlands. 
Although it was unlikely that close contact with the patient beyond 
possibly sharing the same table at breakfast had taken place, the 
supervisors of the travel groups, the respective German state 
health departments and the national public health institute in the 
Netherlands were informed about the case on 21 October. The 
respective federal state or country authorities were provided with 
information about the travel parties, including contact information 
for the group supervisors, to enable an assessment of the possible 
need for chemoprophylaxis and appropriate counselling by the 
responsible health authorities. A number of individual travellers 
from Germany and from other European countries also stayed at 
the hostel. However, as the investigations did not indicate close 
contact between the patient and these travellers, further contact 
tracing was not initiated. No secondary cases have occurred to our 
knowledge. 
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In response to a large number of queries from the public and the 
media, the local health department established a public telephone 
hotline on 21 October. In addition, a third press release was issued 
by the Berlin health authorities on 22 October, which again informed 
about symptoms and transmission of meningococcal disease, and 
reported that close contacts of the patient during her visits to the 
club had contacted the health department and had been advised 
to obtain chemoprophylaxis. The young woman travelling to Berlin 
in the same compartment as the patient also contacted the health 
department and received chemoprophylaxis. 
Discussion
This incident illustrates that close cooperation between German 
and Swiss health authorities led to rapid identification of potential 
close contacts. However, as the case was notified on a Sunday, 
contact tracing in Berlin was delayed until Monday morning 
and informing potential close contacts that had already left the 
hostel was not possible until 21 October, three days after the last 
potential contact with the infectious patient. Perhaps because of 
the excellent communication between the health departments in 
Berlin and Basel, and because of the reporting via EWRS, German 
authorities neglected to directly inform the national health authority 
in Switzerland, which does not have access to EWRS. In addition, 
neither the German nor the Swiss authorities informed each other 
in advance of the press releases they issued. Therefore, this event 
shows that there is still room for improvement concerning the 
international information exchange. More efficient communication 
within the European region could be achieved if Switzerland was 
to participate in the EWRS.
Moreover, this case illustrates the difficulty of deciding which 
persons require chemoprophylaxis. It is well established that 
short-term treatment with rifampicin, ciprofloxacin or ceftriaxone 
eradicates carriage of meningococci in the nasopharynx [1] and 
lowers the risk of secondary cases in household contacts [2]. 
Evidence that chemoprophylaxis lowers the risk of secondary 
cases in other settings is less strong, but it is generally agreed 
that contact with nasopharyngeal secretions, as might occur during 
kissing or after close contact in a confined space (such as during 
travel) warrants chemoprophylaxis, although there is heterogeneity 
in the definition of close contacts, as well as in duration and 
proximity criteria for fellow travellers/contacts of cases, among 
European countries [3]. In this case, chemoprophylaxis was 
definitely considered to be warranted in fellow classmates and 
persons who had had close contact with the patient in a club and 
during an overnight trip in the same train compartment, as the 
latter had taken place less than seven days prior to symptom onset. 
Assessment was more difficult with regard to the other inhabitants 
of the hostel, although close contact was unlikely to have occurred 
by having breakfast in the same room or even at the same table. 
It was left to the discretion of the responsible health authorities to 
assess whether close contact with the patient might, nonetheless, 
have occurred or could be ruled out. It turned out that all nine 
students and three supervisors of one of the German travel groups 
obtained chemoprophylaxis in Berlin on their own initiative prior 
to their departure on 22 October; while local health authorities 
decided that chemoprophylaxis was not necessary for members of 
the remaining two travel groups from Germany or the Dutch group. 
No secondary cases occurred in these groups as documented by 
follow-up as of 31 October.
Conclusion
In summary, this occurrence of fatal invasive meningococcal 
disease in a Swiss student while visiting Berlin highlights the 
importance of early disease notification. In addition, all levels 
of the public health system should be accessible and ready to 
respond at all times. Excellent communication between local health 
departments in Berlin and Basel led to successful identification of 
close contacts across European borders. When an infectious disease 
requiring public health action occurs in an international context, it 
is vital that relevant information is communicated to all levels of 
the public health systems of the countries involved.
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